RHJA
IPXL

Rice Hall James & Associates’s Impax Laboratories, Inc. IPXL Stock Holding History

Rice Hall James & Associates’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-425,629
Closed -$10.1M – 317
2016
Q3 		$10.1M Buy
+425,629
New +$11.4M 0.53% 76

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Rice Hall James & Associates's IPXL Position: Q4 2016 in Review

Rice Hall James & Associates sold out of Impax Laboratories, Inc. (IPXL) in Q4 2016, closing a stake of 425,629 shares — an estimated $10.1M sold.

Rice Hall James & Associates first reported a position in IPXL in Q3 2016 and held it in 1 quarter. The position peaked at $10.1M in Q3 2016. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

  • Rice Hall James & Associates reported no remaining Impax Laboratories, Inc. position as of Q4 2016 after selling out during the quarter.
  • Rice Hall James & Associates sold 425,629 Impax Laboratories, Inc. shares in Q4 2016, an estimated $10.1M.
  • Rice Hall James & Associates first reported a position in Impax Laboratories, Inc. in Q3 2016 and held it in 1 quarter.
  • Rice Hall James & Associates's Impax Laboratories, Inc. position peaked at $10.1M in Q3 2016.
  • 198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on Rice Hall James & Associates's 13F filing for Q4 2016, filed 2 Feb 2017.